We are a U.S. investor-owned, independent, pure-play technology foundry that offers advanced semiconductor development and manufacturing services from our fabrication facility, or fab, in Minnesota and advanced packaging services from our Florida facility. In our technology as a service model, we leverage a strong foundation of proprietary technology to co-develop process technology IP with our […]

Our mission is to enable employees to make smarter security decisions every day.  KnowBe4 developed the leading security awareness platform enabling organizations to assess, monitor and minimize the cybersecurity threat of social engineering attacks. We are pioneering an integrated approach to security awareness that incorporates cloud-based software, machine learning, AI, advanced analytics and insights with engaging […]

(Note: IPOScoop has No Call on this micro-cap IPO. The company has applied to the NASDAQ for approval to list its common stock.) We are a technology company developing and operating platforms focused on esports and competitive gaming. We operate a licensed online gambling platform, gogawi.com, which is an esports/sportsbook focused on bettors in Asia […]

(Note: TPG Pace Beneficial II Corp. is offering Class A ordinary shares – NOT units, which are more typical of SPACs. This SPAC or blank-check company is incorporated in the Cayman Islands.)  We are focused on sponsoring the public listing of a company that combines attractive business fundamentals with, or with the potential for strong […]

We are a leading software platform for digital media measurement and analytics. Our mission is to increase the effectiveness and transparency of the digital advertising ecosystem. Through our software platform and the metrics it provides, we help preserve the fair value exchange in the digital advertising marketplace. The advertising industry continues to shift from traditional mediums […]

We are a preclinical-stage biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. An irreversible small molecule drug is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional reversible drugs, including […]

We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology […]

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to our mission is the Recursion Operating System that combines an advanced infrastructure layer to generate what we believe is […]

“We co-invented a COVID-19 vaccine candidate with the University of Oxford, which we assigned to Oxford University Innovation, or OUI, to facilitate the license of those rights by OUI to AstraZeneca UK Limited, or AstraZeneca. This vaccine is now known as COVID-19 Vaccine AstraZeneca, which we refer to as AZD1222. AstraZeneca has exclusive worldwide rights […]

Our initial strategy is to identify a business combination target within the Middle East, North Africa (“MENA”) or South & Southeast Asia regions. Although we are not limited to any specific industry, we intend to focus on business combination targets within industries with relatively secure and predictable cash flows and growth. Our strategic partner, Innvotec Limited […]